By Turna Ray
After a failed Phase III trial of Sanofi-Aventis' triple-negative breast cancer candidate iniparib, the drug developer has decided to conduct molecular analysis to try to identify best responders to the drug.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now. Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
The World Health Organization calls for the public release of clinical trial results within a year of the completion of data collection.
In Science this week: measles virus nucleocapsid structure, and more.
African and US health officials work to establish an Africa-wide Centres for Disease Control and Prevention.
Nature has retracted a 2002 epigenetics paper for image manipulation.
This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.